Literature DB >> 22345312

Cohort profile: the Ontario HIV Treatment Network Cohort Study (OCS).

Sean B Rourke1, Sandra Gardner, Ann N Burchell, Janet Raboud, Sergio Rueda, Ahmed M Bayoumi, Mona Loutfy, Curtis Cooper, Marek Smieja, Darien Taylor, Tony DiPede, Wendy Wobeser, Carol Major, Virginia Waring, Mark Fisher, John Cairney, Nicole Mittmann, Irving E Salit, Fred Crouzat, Kevin Gough, Edward Ralph, Roger Sandre, Don Kilby, Anita Rachlis.   

Abstract

The Ontario HIV Treatment Network Cohort Study (OCS) is an observational, open dynamic cohort of people who are receiving medical care for human immunodeficiency virus (HIV) infection in Ontario, Canada. Established in the mid-1990s, the OCS has its roots in AIDS activists' demands for research that would improve the quality of life of people living with HIV while respecting their privacy. It is a collaborative and community-driven study, including a Governance Committee made up of people with HIV and other stakeholders that evaluates analysis project proposals for community relevance and ethics. From 1995 to 2010, a total of 5644 participants were enrolled and 27,720 person-years of observation were accumulated; follow-up will continue until at least 2015. In the initial years of study, the focus was on clinical data from medical chart reviews. It has since evolved into a comprehensive study that collects extensive de-identified information on clinical, laboratory and psychosocial and behavioural measures based on medical chart abstractions, interviews using a standardized questionnaire and linkage with external administrative health databases in Ontario. Interested collaborators are encouraged to submit analysis project proposals as instructed on the study website (www.ohtncohortstudy.ca).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22345312     DOI: 10.1093/ije/dyr230

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  28 in total

1.  National characteristics and trends in antiretroviral treatment in Australia can be accurately estimated using a large clinical cohort.

Authors:  Robin Huang; Kathy Petoumenos; Richard T Gray; Hamish McManus; Nila Dharan; Rebecca Guy; David A Cooper
Journal:  J Clin Epidemiol       Date:  2018-04-25       Impact factor: 6.437

2.  Stigma, Coping, and Alcohol Use Severity Among People Living With HIV: A Prospective Analysis of Bidirectional and Mediated Associations.

Authors:  Jeffrey D Wardell; Paul A Shuper; Sean B Rourke; Christian S Hendershot
Journal:  Ann Behav Med       Date:  2018-08-16

3.  Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study.

Authors:  Adriana Carvalhal; M John Gill; Scott L Letendre; Anita Rachlis; Tsegaye Bekele; Janet Raboud; Ann Burchell; Sean B Rourke
Journal:  J Neurovirol       Date:  2015-11-16       Impact factor: 2.643

4.  Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals.

Authors:  Jennifer Gillis; Curtis Cooper; Sean Rourke; Sergio Rueda; Kelly O'Brien; Evan Collins; Anita Rachlis; Trevor A Hart; Janet Raboud
Journal:  Qual Life Res       Date:  2012-10-17       Impact factor: 4.147

5.  Lost but not forgotten: A population-based study of mortality and care trajectories among people living with HIV who are lost to follow-up in Ontario, Canada.

Authors:  C E Kendall; J Raboud; J Donelle; M Loutfy; S B Rourke; A Kroch; C Liddy; R Rosenes; A N Burchell
Journal:  HIV Med       Date:  2018-11-26       Impact factor: 3.094

6.  Hepatitis C virus seroconversion among HIV-positive men who have sex with men with no history of injection drug use: Results from a clinical HIV cohort.

Authors:  Ann N Burchell; Sandra L Gardner; Tony Mazzulli; Michael Manno; Janet Raboud; Vanessa G Allen; Ahmed M Bayoumi; Rupert Kaul; Frank McGee; Peggy Millson; Robert S Remis; Wendy Wobeser; Curtis Cooper; Sean B Rourke
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 Jan-Feb       Impact factor: 2.471

7.  Representativeness of an HIV cohort of the sites from which it is recruiting: results from the Ontario HIV Treatment Network (OHTN) cohort study.

Authors:  Janet Raboud; DeSheng Su; Ann N Burchell; Sandra Gardner; Sharon Walmsley; Ahmed M Bayoumi; Sandra Blitz; Curtis Cooper; Irving Salit; Jeff Cohen; Sean B Rourke; Mona R Loutfy
Journal:  BMC Med Res Methodol       Date:  2013-03-05       Impact factor: 4.615

8.  Influence of employment and job security on physical and mental health in adults living with HIV: cross-sectional analysis.

Authors:  Sergio Rueda; Janet Raboud; Sean B Rourke; Tsegaye Bekele; Ahmed Bayoumi; John Lavis; John Cairney; Cameron Mustard
Journal:  Open Med       Date:  2012-10-01

9.  Patterns of syphilis testing in a large cohort of HIV patients in Ontario, Canada, 2000-2009.

Authors:  Ann N Burchell; Vanessa G Allen; Veronika Moravan; Sandra Gardner; Janet Raboud; Darrell H S Tan; Ahmed M Bayoumi; Rupert Kaul; Tony Mazzulli; Frank McGee; Peggy Millson; Robert S Remis; Sean B Rourke
Journal:  BMC Infect Dis       Date:  2013-05-28       Impact factor: 3.090

10.  High incidence of diagnosis with syphilis co-infection among men who have sex with men in an HIV cohort in Ontario, Canada.

Authors:  Ann N Burchell; Vanessa G Allen; Sandra L Gardner; Veronika Moravan; Darrell H S Tan; Ramandip Grewal; Janet Raboud; Ahmed M Bayoumi; Rupert Kaul; Tony Mazzulli; Frank McGee; Sean B Rourke
Journal:  BMC Infect Dis       Date:  2015-08-20       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.